Vera Therapeutics VERA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's operating income?
- Vera Therapeutics (VERA) reported operating income of -$125.13M in Q1 2026.
- How has Vera Therapeutics's operating income changed year-over-year?
- Vera Therapeutics's operating income decreased by 118.8% year-over-year, from -$57.19M to -$125.13M.
- What is the long-term trend for Vera Therapeutics's operating income?
- Over 4 years (2021 to 2025), Vera Therapeutics's operating income has grown at a 74.0% compound annual growth rate (CAGR), from -$34.4M to -$315.47M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.